Rafael-Vidal, C.; Altabás, I.; Pérez, N.; Mourino RodrÃguez, C.; Pego-Reigosa, J.M.; Garcia, S.
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis. Int. J. Mol. Sci. 2021, 22, 1263.
https://doi.org/10.3390/ijms22031263
AMA Style
Rafael-Vidal C, Altabás I, Pérez N, Mourino RodrÃguez C, Pego-Reigosa JM, Garcia S.
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis. International Journal of Molecular Sciences. 2021; 22(3):1263.
https://doi.org/10.3390/ijms22031263
Chicago/Turabian Style
Rafael-Vidal, Carlos, Irene Altabás, Nair Pérez, Coral Mourino RodrÃguez, Jose M. Pego-Reigosa, and Samuel Garcia.
2021. "Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis" International Journal of Molecular Sciences 22, no. 3: 1263.
https://doi.org/10.3390/ijms22031263
APA Style
Rafael-Vidal, C., Altabás, I., Pérez, N., Mourino RodrÃguez, C., Pego-Reigosa, J. M., & Garcia, S.
(2021). Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis. International Journal of Molecular Sciences, 22(3), 1263.
https://doi.org/10.3390/ijms22031263